SCYNEXIS, Inc.(SCYX)- NASDAQ
From other sites
Company Description
SCYNEXIS, Inc. engages in discovery, development and commercialization of novel anti infective to address significant unmet therapeutic needs. It develops candidate, SCY-078, as a novel oral and intravenous drug for the treatment of serious and life-threatening invasive fungal infections in... More
Sector: Healthcare
Industry: Drugs - Generic
Country: United States